Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum - Xu, Bingdong; Ling, Yitong; Liu, Leiyuan; Liu, Yujun; Lin, Yingze; Lyu, Jun; Zhang, Yusheng (BMC geriatrics, 2024)
Keywords: Accuracy; Advertising executives; Aged; Aged, 80 and over; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - diagnosis; Alzheimer Disease - metabolism; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-Peptides - metabolism; Biomarkers; Biomarkers - cerebrospinal fluid; Cerebrospinal fluid; Chromatography; Cognitive ability; Cognitive Dysfunction - cerebrospinal fluid; Cognitive Dysfunction - diagnosis; Cognitive function; Cohort Studies; Dementia; Development and progression; Disease Progression; Diseases; Female; Follow-Up Studies; Health aspects; Hippocampus; Humans; Male; Mass spectrometry; Mediation; Medical prognosis; Memory; Methods; Middle Aged; Neurodegenerative diseases; Neuropsychology; Older people; Peptides; Predictive Value of Tests; Prognosis; Proteins; Proteomics; Proteomics - methods; Scientific imaging; Software; Tau protein; tau Proteins - cerebrospinal fluid; China; Biomarkers; Prognosis; Alzheimer’s disease; Cognitive function; Proteomics